动物性寄生虫纳米疫苗:进展,挑战和未来前景
Qiangqiang Wang1,2, Bin Hu1,2, Yuanfeng Wang3
1Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang, Henan, P. R. China.
Integrative zoology
|December 24, 2025
概括
纳米粒子疫苗显示出对寄生虫感染的承诺,克服了传统方法的挑战. 本综述详细介绍了进展,分析了障碍,并为开发下一代寄生虫纳米疫苗提供了前景.
科学领域:
- * 寄生虫学和疫苗学
- * 纳米技术在医学中的应用
背景情况:
- * 寄生虫感染是全球重要的健康问题,特别是在低收入和中等收入国家.
- * 传统疫苗面临的局限性是由于寄生虫的复杂性和免疫逃避策略.
- * 基于纳米粒子的疫苗 (例如mRNA脂质,聚合物,病毒样颗粒) 显示出增强的免疫性.
研究的目的:
- * 审查针对寄生虫感染的基于纳米粒子的疫苗的最新进展.
- *详细介绍不同类型的纳米粒子在疫苗开发中的作用.
- *分析挑战,并为寄生虫纳米疫苗提供未来的前景.
主要方法:
- * 针对寄生虫感染的纳米粒子基础疫苗的综合文献综述.
- *分析各种纳米粒子平台 (mRNA脂质,聚合物,VLP).
- * 检查临床,伦理和监管方面的挑战.
主要成果:
- *纳米粒子疫苗,包括mRNA脂质颗粒,聚合物颗粒和病毒样颗粒 (VLPs),为传统疫苗提供了一个有希望的替代方案.
- *这些纳米疫苗在临床前和临床试验中表现出改善的免疫性.
- * 寄生虫纳米疫苗的临床转化和监管批准仍然存在重大挑战.
结论:
- * 基于纳米粒子的疫苗代表了对抗寄生虫感染的重大进展.
- * 解决临床,伦理和监管障碍对于成功实施至关重要.
- *需要进一步的研究来开发下一代寄生虫纳米疫苗.
更多相关视频
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.7K
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
5.0K
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
911
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
911
01:51Vaccinations
51.1K
Overview
51.1K
01:22Development of Immunocompetence
769
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
769